Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Biotechnology

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Comment by deelongon Sep 18, 2015 6:02pm

81 Views

Post# 24117417

RE:Will this private placement not further dilute the shares

I guess it all depends on how the company can advance and grow should they fill this private placement. Maybe they can ramp up sales and push out new products and this will be a very positive step.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?